Article Details

Myasthenia Gravis (MG) Treatment Industry Forecast to 2030: - GlobeNewswire

Retrieved on: 2024-04-17 14:08:39

Tags for this article:

Click the tags to see associated articles and topics

Myasthenia Gravis (MG) Treatment Industry Forecast to 2030: - GlobeNewswire. View article details on HISWAI: https://www.globenewswire.com/news-release/2024/04/17/2864286/0/en/Myasthenia-Gravis-MG-Treatment-Industry-Forecast-to-2030-A-2-5-Billion-Market-Dominated-by-Alexion-Pharma-Grifols-Avadel-Pharma-Novartis-Pfizer-AbbVie-and-Roche.html

Excerpt

Pfizer; AbbVie; F. Hoffmann-La Roche. Myasthenia Gravis Treatment Market Insights. Monoclonal antibodies will remain the largest segment over the ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up